Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : Auric Goldfinger's Short List -- Ignore unavailable to you. Want to Upgrade?

To: RockyBalboa who wrote (14902)	3/31/2005 6:32:32 PM
From: RockyBalboa	Respond to of 19428

Castro & Berguido Vallarino Building, 6th Floor, Elvira Mendez Street, P.O. Box 4413 Panamá 5, Panama Telephone: +507 264-0506; 264-0519; 263-0015 Telefax: +507 264-0516 Email: Contact Us Web Site: castroberguido.com Firm Credentials Statement of Practice: General Practice, Corporate, Offshore Corporations, Commercial, Offshore Trust and Foundations, Labor, Maritime, Banking. Firm Size: 5 Other Office Addresses: Nassau, Bahamas Office: Boye's Chambers, Montrose Avenue No. 21, P.O. Box C-B-13278. Fax: +242 326-8024. British Virgin Islands Office: In Association with Aramo Trust Co. Limited, International Trust Building, P.O. Box 659, Road Town, Tortola, British Virgin Islands

To: RockyBalboa who wrote (14902)	3/31/2005 6:50:47 PM
From: StockDung	Respond to of 19428

google.com

To: RockyBalboa who wrote (14902)	3/31/2005 10:26:44 PM
From: SEC-ond-chance	Read Replies (2) \| Respond to of 19428

Who is George Minto, the author of Bio-Heal (OTC: BHLL) Refutes The Our Street Report of Yesterday George K. Minto Secretary/Treasurer Bio-Heal Laboratories, Inc. George Minto. Mr. Minto has been the president and director of Nutra Pharma, Inc. since May, 2001, and a director of Nutra Pharma, Inc. since November, 2001. He has also served as the president of Diagnostic Resources since 1999. He has acted as the Managing Director of Satori Group Trust for the past 30 years. Mr. Minto holds a degree in physiotherapy from the SAME Institute in Belfast, Ireland, and received pre-medical education at the Queens University in Belfast. secinfo.com Nutra Pharma Corp · On December 3, 2001, we issued 4,500,000 shares of restricted common stock to George Guy??? Minto, in exchange for the assets of Nutra Pharma, Inc., which consisted of a license agreement with TerraBioPharma, S.A., for the worldwide distribution rights to TerraBioPharma's botanical medicinal compound. On October 23, 2002, Mr. Minto returned 1,787,500 shares of Nutra Pharma common stock to the Company for cancellation based on negotiations between the Company and Mr. Minto. On December 23, 2002, Nutra Pharma Corp. and Nutra Pharma Inc. mutually agreed to rescind their agreement dated November 23, 2001. The prior agreement entitled Nutra Pharma Corp. to acquire all assets of Nutra Pharma Inc. for 4,500,000 shares of Nutra Pharma Corp. All shares were disbursed to George Minto as the sole shareholder of Nutra Pharma Inc. All shares available will be returned to Nutra Pharma Corp, all other shares not returned to Nutra Pharma Corp. will be deemed irretrievable and cancelled upon the agreement. The final terms and conditions of the agreement are as follows: George Minto and Nutra Pharma Inc. will return 2,092,500 shares of Nutra Pharma Corp. in return for 250,000 free-trading shares of Nutra Pharma Corp. George Minto will deliver an additional 1,000,000 shares of Nutra Pharma Corp. and receive 200,000 shares of Nutra Pharma Corp. The remaining 1,407,500 shares will be deemed irretrievable and cancelled. As a result of the cancellation of the above agreement, the Company will remove the asset and corresponding liability from its balance sheet for the year ended December 31, 2002. This will result in a decrease of approximately $1,750,000 in assets and a decrease of approximately $1,750,000 in liabilities on Nutra Pharma Corp.'s balance sheet dated December 31, 2002.